CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA
Purpose: an assessment of clinical efficiency and carrying out the pharmacoeconomic analysis of allergen immunotherapy at patients with mild and moderate allergic bronchial asthma.Materials and methods. 108 patients were examined with mild and moderate allergic bronchial asthma, of both sexes who we...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-09-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/102 |
| _version_ | 1826567991953719296 |
|---|---|
| author | Elena Albertovna Sobko Natalya Vladimirovna Gordeeva Angelina Yurievna Kraposhina Irina Anatolyevna Soloveva Svetlana Vladimirovna Chubarova Olga Petrovna Ishenko Irina Vladimirovna Demko Maria Michailovna Loktionova |
| author_facet | Elena Albertovna Sobko Natalya Vladimirovna Gordeeva Angelina Yurievna Kraposhina Irina Anatolyevna Soloveva Svetlana Vladimirovna Chubarova Olga Petrovna Ishenko Irina Vladimirovna Demko Maria Michailovna Loktionova |
| author_sort | Elena Albertovna Sobko |
| collection | DOAJ |
| description | Purpose: an assessment of clinical efficiency and carrying out the pharmacoeconomic analysis of allergen immunotherapy at patients with mild and moderate allergic bronchial asthma.Materials and methods. 108 patients were examined with mild and moderate allergic bronchial asthma, of both sexes who were divided into 4 groups depending on their therapy. The period of observation was 12 months. The 1st group were included 35 patients of mild allergic bronchial asthma receiving allergen immunotherapy in combination with antiinflammatory therapy; the 2nd group were consisted of 22 patients of mild allergic bronchial asthma using only basic therapy; in the 3rd group 17 patients of moderate allergic bronchial asthma receiving allergen immunotherapy in combination with antiinflammatory medicine were observed; the 4th group was made by 34 patients of moderate allergic bronchial asthma receiving only basic therapy. At all patient were investigated the function of external respiration, scarification tests, test АСТтм. For the pharmacoeconomic analysis we used the cost-effectiveness ratio.Results. Our analysis showed that the scheme of treatment at patients of the 3rd group was economically more profitable in comparison with the scheme of treatment at patients of the 4th group. So at the 3rd group in the end of the period of observation was noted significant improvement of the following indicators: FEV1, decrease of day and night dyspnea attacks, quantity of exacerbations, increase of total point of АСТтм test. Despite the larger value of coefficient of expensive efficiency at patients of the 1st group in comparison with the 2nd group, it is necessary to consider that the allergen immunotherapy interferes the progressing of the disease that will compensate the cost of this method of treatment in the future.Conclusion. We received the results that showed the efficiency of the timely done allergen immunotherapy at patients with the mild and moderate allergic bronchial asthma, and is able tto reduce financial expenses considerably. |
| first_indexed | 2024-04-10T02:40:39Z |
| format | Article |
| id | doaj.art-dc3c201505f44990a3dfe7161813d283 |
| institution | Directory Open Access Journal |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| last_indexed | 2025-03-14T11:16:21Z |
| publishDate | 2015-09-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj.art-dc3c201505f44990a3dfe7161813d2832025-03-02T10:15:50ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-09-0182293710.17749/2070-4909.2015.8.2.029-03792CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMAElena Albertovna Sobko0Natalya Vladimirovna Gordeeva1Angelina Yurievna Kraposhina2Irina Anatolyevna Soloveva3Svetlana Vladimirovna Chubarova4Olga Petrovna Ishenko5Irina Vladimirovna Demko6Maria Michailovna Loktionova7Krasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian Federation; Regional state budget health agency "Regional Clinical Hospital"Krasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian FederationKrasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian FederationKrasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian FederationKrasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian Federation; Regional state budget health agency "Regional Clinical Hospital"Regional state budget health agency "Regional Clinical Hospital"Krasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian FederationKrasnoyarsk budgetary state medical university named after prof. V.F. Voino-Yasenetsky, ministry of public health service of the Russian FederationPurpose: an assessment of clinical efficiency and carrying out the pharmacoeconomic analysis of allergen immunotherapy at patients with mild and moderate allergic bronchial asthma.Materials and methods. 108 patients were examined with mild and moderate allergic bronchial asthma, of both sexes who were divided into 4 groups depending on their therapy. The period of observation was 12 months. The 1st group were included 35 patients of mild allergic bronchial asthma receiving allergen immunotherapy in combination with antiinflammatory therapy; the 2nd group were consisted of 22 patients of mild allergic bronchial asthma using only basic therapy; in the 3rd group 17 patients of moderate allergic bronchial asthma receiving allergen immunotherapy in combination with antiinflammatory medicine were observed; the 4th group was made by 34 patients of moderate allergic bronchial asthma receiving only basic therapy. At all patient were investigated the function of external respiration, scarification tests, test АСТтм. For the pharmacoeconomic analysis we used the cost-effectiveness ratio.Results. Our analysis showed that the scheme of treatment at patients of the 3rd group was economically more profitable in comparison with the scheme of treatment at patients of the 4th group. So at the 3rd group in the end of the period of observation was noted significant improvement of the following indicators: FEV1, decrease of day and night dyspnea attacks, quantity of exacerbations, increase of total point of АСТтм test. Despite the larger value of coefficient of expensive efficiency at patients of the 1st group in comparison with the 2nd group, it is necessary to consider that the allergen immunotherapy interferes the progressing of the disease that will compensate the cost of this method of treatment in the future.Conclusion. We received the results that showed the efficiency of the timely done allergen immunotherapy at patients with the mild and moderate allergic bronchial asthma, and is able tto reduce financial expenses considerably.https://www.pharmacoeconomics.ru/jour/article/view/102bronchial asthmaallergen immunotherapypharmacoeconomiccost-effectiveness analysis |
| spellingShingle | Elena Albertovna Sobko Natalya Vladimirovna Gordeeva Angelina Yurievna Kraposhina Irina Anatolyevna Soloveva Svetlana Vladimirovna Chubarova Olga Petrovna Ishenko Irina Vladimirovna Demko Maria Michailovna Loktionova CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA Фармакоэкономика bronchial asthma allergen immunotherapy pharmacoeconomic cost-effectiveness analysis |
| title | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA |
| title_full | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA |
| title_fullStr | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA |
| title_full_unstemmed | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA |
| title_short | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA |
| title_sort | clinical efficiency and the pharmacoeconomic analysis of allergen immunotherapy at patients with mild and moderate allergic bronchial asthma |
| topic | bronchial asthma allergen immunotherapy pharmacoeconomic cost-effectiveness analysis |
| url | https://www.pharmacoeconomics.ru/jour/article/view/102 |
| work_keys_str_mv | AT elenaalbertovnasobko clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT natalyavladimirovnagordeeva clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT angelinayurievnakraposhina clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT irinaanatolyevnasoloveva clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT svetlanavladimirovnachubarova clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT olgapetrovnaishenko clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT irinavladimirovnademko clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma AT mariamichailovnaloktionova clinicalefficiencyandthepharmacoeconomicanalysisofallergenimmunotherapyatpatientswithmildandmoderateallergicbronchialasthma |